Join us for important updates on FDA’s latest actions. We will share key learnings from FDA drug advertising and promotion enforcement letters since January and discuss other notable developments relevant to prescription drug marketing, including: 

• key enforcement trends;
• new Payor Communications Draft Guidance;
• status of the “Adequate Provision” requirement for DTC broadcast ads; and
• predictions for the rest of the year.

For questions, contact Ella Peek.